Terpyridine

Terpyridine

SCHEMBL2531483

Cl[Pt+].O.O.[Cl-].c1ccc(-c2cccc(-c3ccccn3)n2)nc1

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Terpyridine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK known ✓ Q06187 1/20 0.41
KDM4E B2RXH2 9/20 0.82
TP53 P04637 4/20 0.82
ALOX15 P16050 4/20 0.82
L3MBTL1 Q9Y468 4/20 0.82
SMN1; SMN2 Q16637 4/20 0.82
CCR1 P32246 3/20 0.82
CCR5 P51681 3/20 0.82
CCR8 P51685 3/20 0.82
LMNA P02545 3/20 0.82
TDP1 Q9NUW8 3/20 0.82
HTT P42858 2/20 0.82
ALPL P05186 2/20 0.82
HSP90AA1 P07900 1/20 0.82
ALPI P09923 1/20 0.82
ALPG P10696 1/20 0.82
MAPK1 P28482 1/20 0.82
METAP1 P53582 2/20 0.64
CYP1A2 P05177 2/20 0.64
POLB P06746 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Terpyridine SCHEMBL2995843 0.98 KDM4E (0.86) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL30610400 0.93 KDM4E (0.95) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL30610399 0.93 KDM4E (0.95) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL5396565 0.91 KDM4E (0.90) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
SCHEMBL30172832 0.91 KDM4E (1.00) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL29357603 0.91 KDM4E (1.00) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
SCHEMBL7964803 0.91 KDM4E (1.00) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL57442 0.91 KDM4E (1.00) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL1451348 0.89 KDM4E (0.78) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL7546808 0.88 KDM4E (0.86) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150311556-A1 PLATINUM ADLAYERED RUTHENIUM NANOPARTICLES, METHOD FOR PREPARING, AND USES THEREOF GEORGETOWN UNIVERSITY (US) 2015-10-29 US disclosed
US-9105934-B2 Platinum adlayered ruthenium nanoparticles, method for preparing, and uses thereof GEORGETOWN UNIVERSITY (US) 2015-08-11 US disclosed
US-20110256469-A1 Platinum Adlayered Ruthenium Nanoparticles, Method for Preparing, and Uses Thereof GEORGETOWN UNIVERSITY (US) 2011-10-20 US disclosed
WO-2003006434-A1 METAL COMPLEXES FOR USE IN BORON NEUTRON CAPTURE THERAPY THE UNIVERSITY OF ADELAIDE (AU) 2003-01-23 WO disclosed